Article
Molecular Genetic and Biochemical Characterization of Hyperphenylalaninemia Based on Expanded Neonatal Screening Data from 2023 to 2024 in the Russian Federation.
International journal of molecular sciences - 21 Jun 2026
Lotnik Ekaterina E, Chukhrova Alena L, Ryadninskaya Nina V, Kadnikova Varvara A, Zakharova Ekaterina Y, Baydakova Galina V, Osadchii Andrey R, Anisimova Inga V, Voronin Sergei V, Kutsev Sergey I, Savostyanov Kirill V, Bilalov Fanil S, Koroteev Alexander L, Trofimov Dmitry Y, Bairova Tatyana A, Seitova Gulnara N, Mordanov Sergei V, Matulevich Svetlana A, Golikhina Tatyana A, Nikolaeva Elena B, Polyakov Aleksander V, Shchagina Olga A
Abstract excerpt
Since January 2023, the Russian Federation has implemented expanded neonatal screening for 36 hereditary disorders, which has changed the diagnostic algorithm for hyperphenylalaninemia/phenylketonuria (HPA/PKU) by introducing tandem mass spectrometry (MS/MS) on the second day of life, followed by confirmatory biochemical and molecular testing in newborns at risk. We analyzed 1247 newborns aged 5-15 days with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
